Morgan Keegan Lowers PT on Health Care REIT To $57

Morgan Keegan has lowered the price target on Health Care REIT HCN from $59.50 to $57 and maintains its Outperform rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetAnalyst RatingsFinancialsMorgan KeeganSpecialized REIT's
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!